Abstract:Nucleic acid-based therapy has emerged as a revolutionary methodology for treatment of the diseases related to protein dysfunction; however, lack of systemically applicable synthetic delivery systems limits its current usage in local applications, particularly for DNA-based therapy with regard to the poor bioavailability in the systemic administrations. To overcome this obstacle, we compiled multiple chemistry-based strategies into the manufacture of the gene delivery formulations to pursue improved tolerability of DNA to the enzymatic degradation in the biological milieu and prolonged retention in the systemic circulation. Here, we constructed a distinctive multilayered functional architecture: plasmid DNA (pDNA) was electrostatically complexed with cationic poly(lysine) (polyplex) as the interior pDNA reservoir, which was further cross-linked by redox-responsive disulfide cross-linking to minimize the occurrence of polyplex disassembly through exchange reaction with the biological charged,components. Still, the pDNA reservoir was spatially protected by a sequential thermoresponsive poly(N-isopropylacrylamide) palisade as the intermediate barrier and a biocompatible hydrophilic poly(ethylene glycol) (PEG) shell with the aim of preventing the accessibility of the biological species, particularly the nuclease degradation to the pDNA payload. Subsequent investigations validated the utilities of these strategies in accomplishing prolonged blood retention. In an attempt to apply this method for tumor therapy, ligand cyclic (Arg-Gly-Asp) peptide was attached at the distal end of PEG, validating prompted tumor-targeted delivery and gene expression of the loaded antiangiogenic gene at the targeted tumor cells and accordingly exerting antiangiogenesis of the tumors for abrogation of tumor growth. Together with its excellent safe profile, the proposed formulation suggests potential utility as a practical gene delivery system for treatment of intractable diseases.

Smart Polymeric Nanoparticles for Cancer Gene Delivery

Polymeric Nanostructure Compiled with Multifunctional Components to Exert Tumor-Targeted Delivery of Antiangiogenic Gene for Tumor Growth Suppression

Polymeric micelles as mighty nanocarriers for cancer gene therapy: a review

Polymeric Nanoparticle-Mediated Gene Delivery for Lung Cancer Treatment

Biomembrane-wrapped gene delivery nanoparticles for cancer therapy

Nonviral Cancer Gene Therapy: Delivery Cascade and Vector Nanoproperty Integration.

Polymeric nanoparticles-Promising carriers for cancer therapy

Emerging trends in nano-carrier based gene delivery systems for targeted cancer therapy

Stimuli-Responsive Polymeric Nanocarriers for Efficient Gene Delivery

Nanocarrier-based Gene Delivery for Cancer Immunotherapy

Non-viral Gene Delivery for Cancer Immunotherapy.

Advances in Engineered Polymer Nanoparticle Tracking Platforms towards Cancer Immunotherapy—Current Status and Future Perspectives

Combinational Gene Therapy toward Cancer with Nanoplatform: Strategies and Principles

Facile Formation of PAMAM Dendrimer Nanoclusters for Enhanced Gene Delivery and Cancer Gene Therapy

Recent advances in targeted gene silencing and cancer therapy by nanoparticle-based delivery systems

Anticancer use of nanoparticles as nucleic acid carriers

Cancer‐Targeting Nanoparticles for Combinatorial Nucleic Acid Delivery

Recent Advances and Challenges in Gene Delivery Mediated by Polyester-Based Nanoparticles

Advances in intelligent DNA nanomachines for targeted cancer therapy

Polymer Nanoparticles and Nanomotors Modified by DNA/RNA Aptamers and Antibodies in Targeted Therapy of Cancer

Advanced materials for co-delivery of drugs and genes in cancer therapy